Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
MCG Releases 28th Edition of Guidelines with New Support for the 2024 Medicare Advantage Final Rule | ||
By: PR Newswire Association LLC. - 27 Feb 2024 | Back to overview list |
|
Leading publisher of unbiased, evidence-based clinical guidance incorporates changes to support CMS-4201-F compliance SEATTLE, Feb. 27, 2024 /PRNewswire-PRWeb/ -- MCG Health, part of the Hearst Health network and an industry leader in technology-enabled evidence-based guidance, announces the release of its 28th edition of the MCG care guidelines. Many new changes to the industry-leading guidelines were made to help payers and providers support compliance with the 2024 Medicare Advantage and Part D Final Rule (CMS-4201-F) which was announced by the Centers for Medicare & Medicaid Services (CMS) in April 2023. "This past year has seen some extraordinary work by the MCG clinical and technology teams as they help our payer and provider clients adapt to a rapidly changing regulatory landscape." - Jon Shreve, President & CEO, MCG Health MCG care guidelines are among the most widely used clinical guidelines in the healthcare industry. They are currently licensed by a majority of U.S. health plans, over 3,100 hospitals, and several state and federal agencies. For the 28th edition, MCG clinical editors reviewed 217,640 scientific articles leading to a total of 48,137 unique citations in the MCG evidence base (including 5,565 brand new citations). For the 28th edition, clinical experts enhanced MCG Inpatient & Surgical Care, Multiple Condition Management, Ambulatory Care, General Recovery Care, and Recovery Facility Care guidelines with Supplemental Medicare Criteria and new evidence summaries. The updates were designed to help payers and providers support compliance with the 2024 Medicare Advantage and Part D Final Rule (CMS-4201-F). For its software solution suites, Cite and Indicia, MCG made parallel updates to support visibility of the criteria and evidence summaries. In addition, MCG Cite for Guideline Transparency includes new enhancements that will allow Medicare Advantage payers to share the evidence supporting their coverage decisions more efficiently with providers and current (or prospective) health plan members. Additional updates in the 28th edition include:
Regarding the 28th edition, MCG President and CEO, Jon Shreve, said, "This past year has seen some extraordinary work by the MCG clinical and technology teams as they help our payer and provider clients adapt to a rapidly changing regulatory landscape. I am confident that these new updates will help our customers meet compliance with CMS rules while continuing to drive healthcare decisions with the best available scientific evidence." MCG clients will learn more about the new updates in the 28th edition through training webinars available on the MCG website at: https://www.mcg.com/client-resources/education-training/escholar-webinar-training/. In addition, MCG will hold several educational sessions related to the 28th edition at their annual Client Forum in Phoenix, Arizona (April 22-24). About MCG Health About Hearst Health Media Contact Arri, Burgess, (206) 389-5405, arri.burgess@mcg.com, https://www.mcg.com/ View original content to download multimedia:https://www.prweb.com/releases/mcg-releases-28th-edition-of-guidelines-with-new-support-for-the-2024-medicare-advantage-final-rule-302069648.html SOURCE MCG Health |
||
|
||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |